EIDX
Eidos Therapeutics

290
Loading...
Loading...
BridgeBio is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients. The BridgeBio approach combines a traditional focus on drug development with a unique corporate model, allowing rapid translation of early stage science into medicines that treat disease at its source.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Eidos Therapeutics Inc?
What is the 52-week high for Eidos Therapeutics Inc?
What is the 52-week low for Eidos Therapeutics Inc?
What is Eidos Therapeutics Inc stock price today?
What was Eidos Therapeutics Inc stock price yesterday?
What is the PE ratio of Eidos Therapeutics Inc?
What is the Price-to-Book ratio of Eidos Therapeutics Inc?
What is the 50-day moving average of Eidos Therapeutics Inc?

Latest EIDX News

View
No EIDX news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.